Univest
Univest
  • Markets
  • 3 Contract Pharmaceuticals Maker, Global IT Services Company and Air Conditioning Company Stocks With a Strong Future Roadmap: Innova Captab, Infosys and Blue Star

    • November 12, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Contract Pharmaceuticals Maker, Global IT Services Company and Air Conditioning Company Stocks With a Strong Future Roadmap: Innova Captab, Infosys and Blue Star

    Drug Maker, IT Services and Cooling Stocks with a strong future roadmap: Innova Captab, Infosys and Blue Star. Compare price, valuation, return on equity and revenue growth as of 11 November 2026.

    read more
  • 3 Contract Drug Development and Manufacturing Company, Branded Medicines Maker and Fluorospecialty Chemicals Group Stocks With a Strong Future Roadmap: Anthem Biosciences, Torrent Pharmaceuticals and SRF

    • October 30, 2026
    • Posted by: Lakshit Sharma
    • Category: Best Stocks
    No Comments
    3 Contract Drug Development and Manufacturing Company, Branded Medicines Maker and Fluorospecialty Chemicals Group Stocks With a Strong Future Roadmap: Anthem Biosciences, Torrent Pharmaceuticals and SRF

    Contract Pharma, Branded Drug and Fluoro Stocks with a strong future roadmap: Anthem Biosciences, Torrent Pharmaceuticals and SRF. Compare price, valuation, return on equity and revenue growth as of 29 October 2026.

    read more
  • 3 Contract Formulations Company, Research Led Manufacturing Partner and Global Generics Leader Stocks With a Strong Future Roadmap: Innova Captab, Anthem Biosciences and Dr. Reddy’s Laboratories

    • October 29, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Contract Formulations Company, Research Led Manufacturing Partner and Global Generics Leader Stocks With a Strong Future Roadmap: Innova Captab, Anthem Biosciences and Dr. Reddy's Laboratories

    Contract Pharma, Biosciences and Generics Stocks with a strong future roadmap: Innova Captab, Anthem Biosciences and Dr. Reddy’s Laboratories. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.

    read more